Cargando…

Our Clinical Experience in the Treatment of Myasthenia Gravis Acute Exacerbations with a Novel Nanomembrane-Based Therapeutic Plasma Exchange Technology

According to the American Academy of Neurology 2011 guidelines, there is insufficient evidence to support or refute the use of therapeutic plasma exchange (TPE) for myasthenia gravis (MG). The goal of this study was to determine whether a novel nanomembrane-based TPE could be useful in the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonev, Dimitar, Georgieva, Radostina, Vavrek, Evgeniy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322121/
https://www.ncbi.nlm.nih.gov/pubmed/35887784
http://dx.doi.org/10.3390/jcm11144021